Announcing publication of new ESC/EAS dyslipidaemia guidelines
27 August 2016
Posted by: Carmel Hayes
These updated 2016 guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. The guidance includes sections on: the evaluation of laboratory lipid and apolipoprotein parameters; treatment targets; lifestyle modifications to improve the plasma lipid profile; drugs for treatment of hypercholesterolaemia and hypertriglyceridaemia; drugs affecting HDL-cholesterol; managing dyslipidaemias in different clinical settings; monitoring lipids and enzymes in patients on lipid-lowering therapy; and strategies to encourage adoption of healthy lifestyle changes and lipid-modifying therapies.
Publication in full
Slideset
|
|
Email to a Friend